IARYX
Price
$16.94
Change
+$0.03 (+0.18%)
Updated
Jul 3 closing price
Net Assets
743.7M
VGSIX
Price
$29.93
Change
+$0.05 (+0.17%)
Updated
Jul 3 closing price
Net Assets
63.57B
Interact to see
Advertisement

IARYX vs VGSIX

Header iconIARYX vs VGSIX Comparison
Open Charts IARYX vs VGSIXBanner chart's image
Invesco Real Estate Y
Price$16.94
Change+$0.03 (+0.18%)
VolumeN/A
Net Assets743.7M
Vanguard Real Estate Index Investor
Price$29.93
Change+$0.05 (+0.17%)
VolumeN/A
Net Assets63.57B
IARYX vs VGSIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IARYX vs. VGSIX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IARYX is a Buy and VGSIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VGSIX has more cash in the bank: 63.6B vs. IARYX (744M). VGSIX pays higher dividends than IARYX: VGSIX (3.75) vs IARYX (2.38). IARYX was incepted earlier than VGSIX: IARYX (17 years) vs VGSIX (29 years). IARYX (1.00) is less costly to investors than VGSIX (0.27). IARYX is a more actively managed with annual turnover of: 63.00 vs. VGSIX (7.00). IARYX has a lower initial minimum investment than VGSIX: IARYX (1000) vs VGSIX (3000). VGSIX annual gain was more profitable for investors over the last year : 12.01 vs. IARYX (5.78). VGSIX return over 5 years is better than : 35.11 vs. IARYX (4.29).
IARYXVGSIXIARYX / VGSIX
Total Expense Ratio1.000.27370%
Annual Report Gross Expense Ratio1.000.27370%
Fund Existence17 years29 years-
Gain YTD1.8872.99363%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets744M63.6B1%
Annual Yield % from dividends2.383.7564%
Returns for 1 year5.7812.0148%
Returns for 3 years-9.219.66-95%
Returns for 5 years4.2935.1112%
Returns for 10 years-19.8663.80-31%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEUP7.130.11
+1.57%
Neuphoria Therapeutics Inc
APTV72.560.37
+0.51%
Aptiv PLC
TX32.080.05
+0.16%
Ternium SA
PHAR10.58-0.07
-0.66%
Pharming Group NV
BDSX0.27-0.02
-5.37%
Biodesix